86 research outputs found
THE EUROPEAN UNION’S FRAMEWORK FOR CLIMATE CHANGE ADAPTATION: IMPLICATIONS OF AGRICULTURE’S ADAPTATION THROUGH SUSTAINED YIELD GROWTH
Agricultural and Food Policy, Environmental Economics and Policy, Resource /Energy Economics and Policy,
How Does the Limited Base Acre Provision in the 2008 Farm Act Affect Small Farms?
Under the Food, Conservation, and Energy Act of 2008 (Farm Act), U.S. farms with 10 or fewer base acres became ineligible to receive Direct and Countercyclical Payment (DCP) or Average Crop Revenue Election (ACRE) program payments(Section 1101(d) and 1302(d)) from USDA. Limited resource and socially disadvantaged owners are exempt from this “base 10” provision. Eliminating payments on farms with 10 or fewer base acres reduces payments made by USDA Farm Service Agency (FSA) and the cost of administering the DCP and ACRE programs. We examine the characteristics of the farms affected by the limited base acre provision and answer the question: How does the provision affect small farms?US Farm Policy, Limited Base Acres Provision, 2008 Farm Act, Agricultural and Food Policy,
What happened to world trade under COVID-19?
The impacts of the COVID-19 pandemic for industrial production and goods trade have varied across specific goods, services, and trade partners. Christine Arriola, Przemyslaw Kowalski, and Frank van Tongeren write that the unprecedented heterogeneity of changes in trade flows across products, sources and destinations signifies high uncertainty and adjustment costs, and requires additional incentives to adopt new — or to intensify existing — risk mitigation strategies
Antimicrobial Activity of the Rhizospheric Bacillus Species Isolated from Potato (Solanum tuberosum) Organic Farm Soils in the Philippines
The purpose of this study is to determine the potential of rhizospheric bacteria belonging to the genus Bacillus isolated from the organic soil of Solanum tuberosum (potato) as an untapped and promising source of novel antimicrobials to combat infections, particularly multidrug-resistant strains. The rhizospheric Bacillus species were isolated using serial dilution and aerobic cultivation. Hydrolytic exoenzyme production was determined using plate techniques, whereas antimicrobial activity was determined using the cross-streak method and agar-disc diffusion assay. The data indicate that the Bacillus isolates possess antimicrobial property against gram-positive bacterial pathogens. The activities were compared to those of the antibiotic Rifampicin as a control. Notably, several Bacillus isolates inhibited the growth of methicillin-resistant Staphylococcus aureus (MRSA). The top performing Bacillus isolates were identified by 16s rRNA gene sequence analysis, which showed the similarities of the isolates to known soil-associated and plant-growth-promoting species; B. velezensis, B. mojavensis, B. subtilis, B. sonorensis, B. tequilensis, B. clausii, B. amyloliquefaciens, B. altitudinis, and B. siamensis from those sequences available in GENBANK. The present investigation establishes the presence of antagonistic Bacillus species in S. tuberosum's rhizosphere. The findings may form the basis for further investigation of the active compounds produced by the isolates and the mechanisms underlying their antimicrobial activity, while optimizing the culture medium for efficient production of potent antimicrobial compounds to combat infectious agents may further be investigated
Antimicrobial Activity of the Rhizospheric Bacillus Species Isolated from Potato (Solanum tuberosum) Organic Farm Soils in the Philippines
The purpose of this study is to determine the potential of rhizospheric bacteria belonging to the genus Bacillus isolated from the organic soil of Solanum tuberosum (potato) as an untapped and promising source of novel antimicrobials to combat infections, particularly multidrug-resistant strains. The rhizospheric Bacillus species were isolated using serial dilution and aerobic cultivation. Hydrolytic exoenzyme production was determined using plate techniques, whereas antimicrobial activity was determined using the cross-streak method and agar-disc diffusion assay. The data indicate that the Bacillus isolates possess antimicrobial property against gram-positive bacterial pathogens. The activities were compared to those of the antibiotic Rifampicin as a control. Notably, several Bacillus isolates inhibited the growth of methicillin-resistant Staphylococcus aureus (MRSA). The top performing Bacillus isolates were identified by 16s rRNA gene sequence analysis, which showed the similarities of the isolates to known soil-associated and plant-growth-promoting species; B. velezensis, B. mojavensis, B. subtilis, B. sonorensis, B. tequilensis, B. clausii, B. amyloliquefaciens, B. altitudinis, and B. siamensis from those sequences available in GENBANK. The present investigation establishes the presence of antagonistic Bacillus species in S. tuberosum's rhizosphere. The findings may form the basis for further investigation of the active compounds produced by the isolates and the mechanisms underlying their antimicrobial activity, while optimizing the culture medium for efficient production of potent antimicrobial compounds to combat infectious agents may further be investigated
Epidemiology of Multiple Congenital Anomalies in Europe: A EUROCAT Population-Based Registry Study
Background: This study describes the prevalence, associated anomalies, and demographic characteristics of cases of multiple congenital anomalies (MCA) in 19 population-based European registries (EUROCAT) covering 959,446 births in 2004 and 2010. Methods: EUROCAT implemented a computer algorithm for classification of congenital anomaly cases followed by manual review of potential MCA cases by geneticists. MCA cases are defined as cases with two or more major anomalies of different organ systems, excluding sequences, chromosomal and monogenic syndromes. Results: The combination of an epidemiological and clinical approach for classification of cases has improved the quality and accuracy of the MCA data. Total prevalence of MCA cases was 15.8 per 10,000 births. Fetal deaths and termination of pregnancy were significantly more frequent in MCA cases compared with isolated cases (p<0.001) and MCA cases were more frequently prenatally diagnosed (p<0.001). Live born infants with MCA were more often born preterm (p<0.01) and with birth weight<2500 grams (p<0.01). Respiratory and ear, face, and neck anomalies were the most likely to occur with other anomalies (34% and 32%) and congenital heart defects and limb anomalies were the least likely to occur with other anomalies (13%) (p<0.01). However, due to their high prevalence, congenital heart defects were present in half of all MCA cases. Among males with MCA, the frequency of genital anomalies was significantly greater than the frequency of genital anomalies among females with MCA (p<0.001). Conclusion: Although rare, MCA cases are an important public health issue, because of their severity. The EUROCAT database of MCA cases will allow future investigation on the epidemiology of these conditions and related clinical and diagnostic problems
Long term trends in prevalence of neural tube defects in Europe:population based study
STUDY QUESTIONWhat are the long term trends in the total (live births, fetal deaths, and terminations of pregnancy for fetal anomaly) and live birth prevalence of neural tube defects (NTD) in Europe, where many countries have issued recommendations for folic acid supplementation but a policy for mandatory folic acid fortification of food does not exist?METHODSThis was a population based, observational study using data on 11 353 cases of NTD not associated with chromosomal anomalies, including 4162 cases of anencephaly and 5776 cases of spina bifida from 28 EUROCAT (European Surveillance of Congenital Anomalies) registries covering approximately 12.5 million births in 19 countries between 1991 and 2011. The main outcome measures were total and live birth prevalence of NTD, as well as anencephaly and spina bifida, with time trends analysed using random effects Poisson regression models to account for heterogeneities across registries and splines to model non-linear time trends.SUMMARY ANSWER AND LIMITATIONSOverall, the pooled total prevalence of NTD during the study period was 9.1 per 10 000 births. Prevalence of NTD fluctuated slightly but without an obvious downward trend, with the final estimate of the pooled total prevalence of NTD in 2011 similar to that in 1991. Estimates from Poisson models that took registry heterogeneities into account showed an annual increase of 4% (prevalence ratio 1.04, 95% confidence interval 1.01 to 1.07) in 1995-99 and a decrease of 3% per year in 1999-2003 (0.97, 0.95 to 0.99), with stable rates thereafter. The trend patterns for anencephaly and spina bifida were similar, but neither anomaly decreased substantially over time. The live birth prevalence of NTD generally decreased, especially for anencephaly. Registration problems or other data artefacts cannot be excluded as a partial explanation of the observed trends (or lack thereof) in the prevalence of NTD.WHAT THIS STUDY ADDSIn the absence of mandatory fortification, the prevalence of NTD has not decreased in Europe despite longstanding recommendations aimed at promoting peri-conceptional folic acid supplementation and existence of voluntary folic acid fortification.</p
Prevalence of microcephaly in Europe:population based study
OBJECTIVESTo provide contemporary estimates of the prevalence of microcephaly in Europe, determine if the diagnosis of microcephaly is consistent across Europe, and evaluate whether changes in prevalence would be detected using the current European surveillance performed by EUROCAT (the European Surveillance of Congenital Anomalies).DESIGNQuestionnaire and population based observational study.SETTING24 EUROCAT registries covering 570 000 births annually in 15 countries.PARTICIPANTSCases of microcephaly not associated with a genetic condition among live births, fetal deaths from 20 weeks' gestation, and terminations of pregnancy for fetal anomaly at any gestation.MAIN OUTCOME MEASURESPrevalence of microcephaly (1 Jan 2003-31 Dec 2012) analysed with random effects Poisson regression models to account for heterogeneity across registries.RESULTS16 registries responded to the questionnaire, of which 44% (7/16) used the EUROCAT definition of microcephaly (a reduction in the size of the brain with a skull circumference more than 3 SD below the mean for sex, age, and ethnic origin), 19% (3/16) used a 2 SD cut off, 31% (5/16) were reliant on the criteria used by individual clinicians, and one changed criteria between 2003 and 2012. Prevalence of microcephaly in Europe was 1.53 (95% confidence interval 1.16 to 1.96) per 10 000 births, with registries varying from 0.4 (0.2 to 0.7) to 4.3 (3.6 to 5.0) per 10 000 (X-2= 338, df= 23, I-2=93%). Registries with a 3 SD cut off reported a prevalence of 1.74 per 10 000 (0.86 to 2.93) compared with those with the less stringent 2 SD cut off of 1.21 per 10 000 (0.21 to 2.93). The prevalence of microcephaly would need to increase in one year by over 35% in Europe or by over 300% in a single registry to reach statistical significance (PCONCLUSIONSEUROCAT could detect increases in the prevalence of microcephaly from the Zika virus of a similar magnitude to those observed in Brazil. Because of the rarity of microcephaly and discrepant diagnostic criteria, however, the smaller increases expected in Europe would probably not be detected. Clear diagnostic criteria for microcephaly must be adopted across Europe.</p
Recommended from our members
Consumption of Meat, Fish, Dairy Products, and Eggs and Risk of Ischemic Heart Disease.
BACKGROUND: There is uncertainty about the relevance of animal foods to the pathogenesis of ischemic heart disease (IHD). We examined meat, fish, dairy products, and eggs and risk for IHD in the pan-European EPIC cohort (European Prospective Investigation Into Cancer and Nutrition). METHODS: In this prospective study of 409 885 men and women in 9 European countries, diet was assessed with validated questionnaires and calibrated with 24-hour recalls. Lipids and blood pressure were measured in a subsample. During a mean of 12.6 years of follow-up, 7198 participants had a myocardial infarction or died of IHD. The relationships of animal foods with risk were examined with Cox regression with adjustment for other animal foods and relevant covariates. RESULTS: The hazard ratio (HR) for IHD was 1.19 (95% CI, 1.06-1.33) for a 100-g/d increment in intake of red and processed meat, and this remained significant after exclusion of the first 4 years of follow-up (HR, 1.25 [95% CI, 1.09-1.42]). Risk was inversely associated with intakes of yogurt (HR, 0.93 [95% CI, 0.89-0.98] per 100-g/d increment), cheese (HR, 0.92 [95% CI, 0.86-0.98] per 30-g/d increment), and eggs (HR, 0.93 [95% CI, 0.88-0.99] per 20-g/d increment); the associations with yogurt and eggs were attenuated and nonsignificant after exclusion of the first 4 years of follow-up. Risk was not significantly associated with intakes of poultry, fish, or milk. In analyses modeling dietary substitutions, replacement of 100 kcal/d from red and processed meat with 100 kcal/d from fatty fish, yogurt, cheese, or eggs was associated with ≈20% lower risk of IHD. Consumption of red and processed meat was positively associated with serum non-high-density lipoprotein cholesterol concentration and systolic blood pressure, and consumption of cheese was inversely associated with serum non-high-density lipoprotein cholesterol. CONCLUSIONS: Risk for IHD was positively associated with consumption of red and processed meat and inversely associated with consumption of yogurt, cheese, and eggs, although the associations with yogurt and eggs may be influenced by reverse causation bias. It is not clear whether the associations with red and processed meat and cheese reflect causality, but they were consistent with the associations of these foods with plasma non-high-density lipoprotein cholesterol and for red and processed meat with systolic blood pressure, which could mediate such effects.Analyses supported by the UK Medical Research Council (MR/M012190/1), Cancer Research UK (C8221/A19170 and 570/A16491), and the Wellcome Trust (Our Planet Our Health, Livestock Environment and People 205212/Z/16/Z). EPIC-CVD has been supported by the European Union Framework 7 (HEALTH-F2-2012-279233), the European Research Council (268834), the UK Medical Research Council (G0800270 and MR/L003120/1), the British Heart Foundation (SP/09/002 and RG/08/014 and RG13/13/30194), and the UK National Institute of Health Research. The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue
Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l’Education Nationale, Institut National de la Santé et de la Recherche Médicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ), Federal Ministry of Education and Research (BMBF), Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece);
Italian Association for Research on Cancer (AIRC), National Research Council (Italy) and MIUR "Dipartimenti di Eccellenza"(Project D15D18000410001) to the Department of Medical Sciences (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF); Health Research Fund (FIS), PI13/00061 to Granada, PI13/01162 to EPIC-Murcia, Regional Governments of Andalucía, Asturias, Basque Country, Murcia (no. 6236) and Navarra, ISCIII RETIC (RD06/0020) (Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Skåne and Västerbotten (Sweden); Cancer Research UK (14136 to EPICNorfolk; C570/A16491 and C8221/A19170 to EPIC-Oxford), UK Medical Research Council (1000143 to EPIC-Norfolk, MR/M012190/1 to EPIC-Oxford, MC_UU_12015/1 (CL, NJW), and MC_UU_12015/5 (NF), and NIHR Biomedical Research Centre Cambridge: Nutrition, Diet, and Lifestyle Research Theme (IS-BRC-1215-20014) to the MRC Epidemiology Unit Cambridge. Kathryn Bradbury holds the Girdlers’ New Zealand Health Research Council Fellowship. Marinka Steur received Core MRC Unit support through the Nutritional Epidemiology Programme (MC_UU_12015/5) whilst at the MRC Epidemiology Unit, and received funding from the Alpro Foundation whilst at the Cardiovascular Epidemiology Unit. JD holds a BHF Professorship, NIHR Senior Investigator Award, and ERC Senior Investigator Award. The funders play no role in the design of the study; the collection, analysis, and interpretation of the data; or the decision to approve publication of the finished manuscript. The authors assume full responsibility for analyses and interpretation of these data
Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex
The two hemispheres of the human brain differ functionally and structurally. Despite over a century of research, the extent to which brain asymmetry is influenced by sex, handedness, age, and genetic factors is still controversial. Here we present the largest ever analysis of subcortical brain asymmetries, in a harmonized multi-site study using meta-analysis methods. Volumetric asymmetry of seven subcortical structures was assessed in 15,847 MRI scans from 52 datasets worldwide. There were sex differences in the asymmetry of the globus pallidus and putamen. Heritability estimates, derived from 1170 subjects belonging to 71 extended pedigrees, revealed that additive genetic factors influenced the asymmetry of these two structures and that of the hippocampus and thalamus. Handedness had no detectable effect on subcortical asymmetries, even in this unprecedented sample size, but the asymmetry of the putamen varied with age. Genetic drivers of asymmetry in the hippocampus, thalamus and basal ganglia may affect variability in human cognition, including susceptibility to psychiatric disorders
- …